Page last updated: 2024-08-24

fluorodeoxyglucose f18 and alendronate

fluorodeoxyglucose f18 has been researched along with alendronate in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Blake, GM; Eastell, R; Fogelman, I; Frost, ML; Marsden, PK; Moore, AE; Schleyer, PJ; Siddique, M	1

Trials

1 trial(s) available for fluorodeoxyglucose f18 and alendronate

Article	Year
Regional bone metabolism at the lumbar spine and hip following discontinuation of alendronate and risedronate treatment in postmenopausal women. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 2012, Volume: 23, Issue:8 Topics: Absorptiometry, Photon; Aged; Aged, 80 and over; Alendronate; Biomarkers; Bone Density; Bone Density Conservation Agents; Bone Remodeling; Etidronic Acid; Female; Femur; Fluorodeoxyglucose F18; Hip; Humans; Lumbar Vertebrae; Middle Aged; Osteoporosis, Postmenopausal; Positron-Emission Tomography; Radiopharmaceuticals; Risedronic Acid; Treatment Outcome	2012

Article

Year

Regional bone metabolism at the lumbar spine and hip following discontinuation of alendronate and risedronate treatment in postmenopausal women.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 2012, Volume: 23, Issue:8

Topics: Absorptiometry, Photon; Aged; Aged, 80 and over; Alendronate; Biomarkers; Bone Density; Bone Density Conservation Agents; Bone Remodeling; Etidronic Acid; Female; Femur; Fluorodeoxyglucose F18; Hip; Humans; Lumbar Vertebrae; Middle Aged; Osteoporosis, Postmenopausal; Positron-Emission Tomography; Radiopharmaceuticals; Risedronic Acid; Treatment Outcome

2012